Table 4 |
|||
|
Sputum and peripheral blood cellular profiles at baseline |
|||
| β2-agonist alone |
ICS-treated |
Significance |
|
|
|
|||
| *TCC × 103/ml |
41.5 (11.1–235.3) |
30.0 (0.5–293.8) |
NS |
| Sputum eosinophils, % |
4.6 (0.8–20.4) |
6.0 (0.2–39.2) |
NS |
| Cys-LT pg/ml |
266.4 (1.0–1343.6) |
297.6 (60.3–763.1) |
NS |
| PGE2pg/ml |
966 (371.6–1950.5) |
1358,5 (149.1–6155.3) |
NS |
| PB eosinophils, × 109 |
4.3 (1.1–12.7) |
3.3 (1.2–9.8) |
NS |
| PB neutrophils, × 109 |
3.2 (2.0–6.2) |
3.65 (1.1–6.2) |
NS |
| eNO (ppb) |
31 (9–77) |
15 (8–32) |
p < 0.001 |
Reid et al. Journal of Negative Results in BioMedicine 2008 7:3 doi:10.1186/1477-5751-7-3 |
|||
